Dr Randeep Guleria In a major development against Covid-19 pandemic in India, the Centre has approved Serum Institute’s Covishield for emergency authorisation in India. As the country awaits DCGI’s nod on the same, it is conducting one of the biggest vaccine dry runs today to ensure smooth planning and implementation of the immunisation programme. While there is still time for the immunisation process to begin, about 130 crore Indians have surely got their hopes high for a vaccine. To answer some of the most asked questions about the immunisation programme, The Daily Guardian recently got in a conversation with AIIMS director Dr Randeep Guleria and here’s what he said.